Compare PEG & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEG | MDLN |
|---|---|---|
| Founded | 1903 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0B | 31.0B |
| IPO Year | 1994 | 2025 |
| Metric | PEG | MDLN |
|---|---|---|
| Price | $70.09 | $31.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 23 |
| Target Price | ★ $92.79 | $50.48 |
| AVG Volume (30 Days) | 2.3M | ★ 6.6M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.37% | N/A |
| EPS Growth | ★ 19.21 | N/A |
| EPS | ★ 2.15 | 0.23 |
| Revenue | $12,168,000,000.00 | ★ $28,432,000,000.00 |
| Revenue This Year | $4.89 | $10.88 |
| Revenue Next Year | $4.16 | $7.69 |
| P/E Ratio | ★ $33.01 | $139.65 |
| Revenue Growth | ★ 18.25 | 11.47 |
| 52 Week Low | $70.05 | $31.63 |
| 52 Week High | $87.63 | $50.88 |
| Indicator | PEG | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 28.68 | 36.88 |
| Support Level | N/A | N/A |
| Resistance Level | $81.50 | $37.39 |
| Average True Range (ATR) | 1.00 | 1.31 |
| MACD | -0.16 | -0.19 |
| Stochastic Oscillator | 3.80 | 7.01 |
Public Service Enterprise Group is the holding company for a regulated utility (PSE&G) and PSEG Power, which owns all or a share of three nuclear plants and clean energy projects. PSE&G provides regulated gas and electricity delivery services in New Jersey to a combined 4.3 million customers. Public Service Enterprise Group also operates the Long Island Power Authority system under a contract extension through 2030. In 2022, the company sold its gas and oil power plants in the mid-Atlantic, New York, and the Northeast.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.